GREG cells, a dysferlin-deficient myogenic mouse cell line

Experimental Cell Research

Volumn 318, Issue 2, 2012, Pages 127-135

  Humphrey, Glen W ^a   Mekhedov, Elena ^a   Blank, Paul S ^a   de Morree, Antoine ^b   Pekkurnaz, Gulcin ^a   Nagaraju, Kanneboyina ^c   Zimmerberg, Joshua ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Dysferlin; Myoblast; Myotube; Resealing

Indexed keywords

DYSFERLIN;

A J MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL LINE; CELL MEMBRANE; CELL REGENERATION; CONTROLLED STUDY; CULTURE MEDIUM; DYSFERLINOPATHY; GENETIC MODEL; GREG MYOBLAST; LASER; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WOUND;

EID: 82855174727     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.10.004     Document Type: Article

References (26)

1. Bansal D., Campbell K.P. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 2004, 14:206-213.
2. Glover L., Brown R.H. Dysferlin in membrane trafficking and patch repair. Traffic 2007, 8:785-794.
3. Nguyen K., Bassez G., Krahn M., Bernard R., Laforet P., Labelle V., Urtizberea J.A., Figarella-Branger D., Romero N., Attarian S., Leturcq F., Pouget J., Levy N., Eymard B. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch. Neurol. 2007, 64:1176-1182.
4. Weiler T., Bashir R., Anderson L.V., Davison K., Moss J.A., Britton S., Nylen E., Keers S., Vafiadaki E., Greenberg C.R., Bushby C.R., Wrogemann K. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum. Mol. Genet. 1999, 8:871-877.
5. Selcen D., Stilling G., Engel A.G. The earliest pathologic alterations in dysferlinopathy. Neurology 2001, 56:1472-1481.
6. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., McNeil P.L., Campbell K.P. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
7. Lennon N.J., Kho A., Bacskai B.J., Perlmutter S.L., Hyman B.T., Brown R.H. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem. 2003, 278:50466-50473.
8. McNeil A.K., Rescher U., Gerke V., McNeil P.L. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 2006, 281:35202-35207.
9. Ho M., Post C.M., Donahue L.R., Lidov H.G., Bronson R.T., Goolsby H., Watkins S.C., Cox G.A., Brown R.H. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum. Mol. Genet. 2004, 13:1999-2010.
10. Roche J.A., Lovering R.M., Bloch R.J. Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo. Neuroreport 2008, 19:1579-1584.
11. Roche J.A., Lovering R.M., Roche R., Ru L.W., Reed P.W., Bloch R.J. Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries. Am. J. Physiol. Cell Physiol. 2010, 298:C298-C312.
12. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
13. Yasin R., van Beers G., Bulien D., Thompson E.J. A quantitative procedure for the dissociation of adult mammalian muscle into mononucleated cells. Exp. Cell Res. 1976, 102:405-408.
14. Belanto J.J., Diaz-Perez S.V., Magyar C.E., Maxwell M.M., Yilmaz Y., Topp K., Boso G., Jamieson C.H., Cacalano N.A., Jamieson C.A. Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul. Disord. 2010, 20:111-121.
15. Robinson J.M., Vandre D.D. Antigen retrieval in cells and tissues: enhancement with sodium dodecyl sulfate. Histochem. Cell Biol. 2001, 116:119-130.
16. Bezrukov L., Blank P.S., Polozov I.V., Zimmerberg J. An adhesion-based method for plasma membrane isolation: evaluating cholesterol extraction from cells and their membranes. Anal. Biochem. 2009, 394:171-176.
17. Huang Y., Verheesen P., Roussis A., Frankhuizen W., Ginjaar I., Haldane F., Laval S., Anderson L.V., Verrips T., Frants R.R., de Haard H., Bushby K., den Dunnen J., van der Maarel S.M. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. Eur. J. Hum. Genet. 2005, 13:721-730.
18. de Morree A., Hensbergen P.J., van Haagen H.H., Dragan I., Deelder A.M., t Hoen P.A., Frants R.R., van der Maarel S.M. Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity. PLoS One 2010, 5:e13854.
19. Rutgers K.S., van Remoortere A., van Buchem M.A., Verrips C.T., Greenberg S.M., Bacskai B.J., Frosch M.P., van Duinen S.G., Maat-Schieman M.L., van der Maarel S.M. Differential recognition of vascular and parenchymal beta amyloid deposition. Neurobiol. Aging 2011, 32:1774-1783.
20. McNeil P.L., Miyake K., Vogel S.S. The endomembrane requirement for cell surface repair. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4592-4597.
21. Sternberg S.R. Biomedical image processing. IEEE Comput. 1983, 16:22-34.
22. Davis D.B., Doherty K.R., Delmonte A.J., McNally E.M. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 2002, 277:22883-22888.
23. Doherty K.R., Cave A., Davis D.B., Delmonte A.J., Posey A., Earley J.U., Hadhazy M., McNally E.M. Normal myoblast fusion requires myoferlin. Development 2005, 132:5565-5575.
24. Robinson J.M., Ackerman W.E.t., Behrendt N.J., Vandre D.D. While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems. Biol. Reprod. 2009, 81:33-39.
25. Bittner R.E., Anderson L.V., Burkhardt E., Bashir R., Vafiadaki E., Ivanova S., Raffelsberger T., Maerk I., Hoger H., Jung M., Karbasiyan M., Storch M., Lassmann H., Moss J.A., Davison K., Harrison R., Bushby K.M., Reis A. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet. 1999, 23:141-142.
26. Blau H.M., Chiu C.P., Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 1983, 32:1171-1180.